Stefan G. Koenig

Papers

1

Total Citations

63

H-Index

1

About

Stefan G. Koenig is a leading figure in the field of pharmaceutical formulation and drug delivery, with a particular focus on the development and characterization of lipid nanoparticles (LNPs) for nucleic acid therapeutics. His major contributions center on advancing the high-throughput automation of LNP preparation and characterization, a critical step in accelerating the translation of gene-based medicines from bench to bedside. His most-cited work, "Automated high-throughput preparation and characterization of oligonucleotide-loaded lipid nanoparticles" (2021, 63 citations), exemplifies this impact by demonstrating a robust, scalable platform that streamlines the synthesis and quality assessment of LNPs, addressing a key bottleneck in the field. This work has been instrumental in enabling rapid screening of LNP formulations, thereby enhancing the efficiency of preclinical development for RNA-based therapies, including vaccines and gene-editing tools. Through his innovative approach, Koenig has helped bridge the gap between lab-scale discovery and clinical manufacturing, solidifying his reputation as a pivotal contributor to the next generation of drug delivery systems.

Research Focus

Key Achievements

1
H-Index
1
Papers
63
Total Citations
63
Avg Citations/Paper
🏆 Most Cited Paper
Automated high-throughput preparation and characterization of oligonucleotide-loaded lipid nanoparticles
63 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 12

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago